Bide Pharmatech Co., Ltd. (SHA:688073)
China flag China · Delayed Price · Currency is CNY
59.73
+1.68 (2.89%)
At close: Apr 29, 2026

Bide Pharmatech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,1465,2604,3425,0445,333-
Market Cap Growth
18.12%21.13%-13.91%-5.42%--
Enterprise Value
4,2454,3473,2603,9053,860-
Last Close Price
59.7361.0548.1752.7955.15-
PE Ratio
34.5334.6636.9846.0336.53-
Forward PE
25.2627.5631.7422.5030.12-
PS Ratio
3.893.973.944.626.40-
PB Ratio
2.522.572.142.412.57-
P/TBV Ratio
2.532.592.152.422.57-
P/FCF Ratio
1273.641301.7962.06---
P/OCF Ratio
181.68185.6927.43-178.53-
EV/Sales Ratio
3.213.282.963.584.63-
EV/EBITDA Ratio
16.3616.9726.3835.8825.71-
EV/EBIT Ratio
17.5717.9928.9239.3326.74-
EV/FCF Ratio
1050.781075.8146.59---
Debt / Equity Ratio
0.070.070.040.030.020.04
Debt / EBITDA Ratio
0.540.540.580.450.250.23
Debt / FCF Ratio
34.9234.921.18---
Net Debt / Equity Ratio
-0.44-0.44-0.54-0.58-0.71-0.26
Net Debt / EBITDA Ratio
-3.51-3.51-8.89-11.18-9.78-1.49
Net Debt / FCF Ratio
-222.86-222.86-15.7010.27172.021.76
Asset Turnover
0.540.540.460.460.510.86
Inventory Turnover
0.850.850.931.100.940.91
Quick Ratio
3.863.864.125.546.841.31
Current Ratio
6.746.746.398.229.013.28
Return on Equity (ROE)
7.45%7.45%5.71%5.21%10.79%19.65%
Return on Assets (ROA)
6.12%6.12%2.92%2.60%5.53%9.51%
Return on Invested Capital (ROIC)
16.79%18.10%9.93%11.55%22.92%25.82%
Return on Capital Employed (ROCE)
11.10%11.10%5.40%4.60%6.80%16.40%
Earnings Yield
2.95%2.89%2.70%2.17%2.74%-
FCF Yield
0.08%0.08%1.61%-2.35%-0.16%-
Dividend Yield
1.55%-1.87%1.70%1.99%-
Payout Ratio
52.02%52.58%68.03%91.29%0.06%0.19%
Buyback Yield / Dilution
1.40%1.40%1.76%-22.83%-10.09%-8.03%
Total Shareholder Return
3.02%1.40%3.63%-21.13%-8.10%-8.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.